Delivering a robust technology solution for EMIR reconciliations.
Fund Recs deliver a robust technology solution for EMIR reconciliations for their client, a leading investment manager with their own UCITS ManCo.
Read Post
One Year of EMIR Refit: One Year On
Discover how Fund Recs' EMIR solution helped clients tackle new regulatory requirements with ease and efficiency over the past year.
Read Post
Global coverage, local precision
Discover the latest OTC derivatives regulatory updates in Hong Kong and Canada, and learn how to stay compliant with new reporting and risk management...
Read Post
Alchelyst partners with Fund Recs to elevate Fund Operations through Innovation
Alchelyst partners with Fund Recs to enhance fund operations through innovative reconciliation software, addressing industry challenges and modernizing...
Read Post
Hong Kong’s OTC Derivatives Rules: What You Need to Know for 2025
Learn about Hong Kong's new 2025 OTC derivatives regulations and what firms need to do to stay compliant.
Read Post
GemCap Partners with Fund Recs for Advanced EMIR Solution
GemCap partners with Fund Recs to enhance regulatory compliance through advanced EMIR reconciliation solutions, ensuring seamless adherence to evolving...
Read Post
Canada’s OTC Derivatives Rules: What you need to know in 2025
Understand the key updates to Canada's OTC derivatives regulations in 2025, including expanded reporting obligations, new data elements, and exemptions for...
Read Post
Muzinich & Co adopts the Fund Recs platform for EMIR Solution
Muzinich & Co selects Fund Recs' EMIR oversight solution to enhance compliance and streamline operations.
Read Post
EMIR Re-fit: Lessons Learned
This article reflects on key lessons we've learned from EMIR re-fit. Explore data management, reporting flexibility, and governance compliance for regulatory...
Read Post
ASIC Basics: Part one
ASIC’s new OTC derivative reporting rules start 21 Oct 2024. Learn about expanded coverage, stricter timeframes, and compliance essentials..
Read Post